Irbesartan - Irbesartan
Navigation: NDC > Supplier starting with: M > MYLAN PHARMACEUTICALS INC.| Field | Value |
|---|---|
| NDC Code: | 0378-2022 |
| Proprietary Name: | Irbesartan |
| Suffix: | |
| Non-Proprietary Name: | Irbesartan |
| Dosage Form: | TABLET |
| Method: | ORAL |
| Original Marketing Date: | 28-09-2012 |
| Category Name: | ANDA |
| Application Number: | ANDA200461 |
| Labeler: | MYLAN PHARMACEUTICALS INC. |
| Substance Name: | IRBESARTAN |
| Active Numerator Strength: | 75 |
| Active Ingredient Unit: | mg/1 |
| Pharm Classes: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
| DEA Schedule: |